L. Evitt

Burden of asthma exacerbations and health care utilization in pediatric patients with asthma in the US and England

W. Lenney, M. Gokhale, Takako Hattori, 2020, Immunity, inflammation and disease.

Cost and consequences of using 7.1 % chlorhexidine gel for newborn umbilical cord care in Kenya

L. Evitt, Alan Martin, Lecia Brown, 2021, BMC Health Services Research.

HIV Treatment with the Two-Drug Regimen Dolutegravir Plus Lamivudine in Real-world Clinical Practice: A Systematic Literature Review

A. d’Arminio Monforte, J. V. van Wyk, S. Di Giambenedetto, 2021, Infectious Diseases and Therapy.

Incidence, risk factors and re‐exacerbation rate of severe asthma exacerbations in a multinational, multidatabase pediatric cohort study

R. Suruki, F. Albers, K. Verhamme, 2019, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

Effectiveness and safety of dolutegravir two‐drug regimens in virologically suppressed people living with HIV: a systematic literature review and meta‐analysis of real‐world evidence

S. Kaur, A. de Ruiter, L. Evitt, 2021, HIV medicine.

An indirect comparison of 144-week efficacy, safety, and tolerability of dolutegravir plus lamivudine and second-generation integrase inhibitor–based, 3-drug, single-tablet regimens in therapy-naive people with HIV-1

L. Evitt, R. Grove, S. Snedecor, 2023, AIDS Research and Therapy.

898. Effectiveness and Tolerability of DTG + 3TC in Clinical Practice: Evidence in PLHIV from Real-world Data

A. de Ruiter, L. Evitt, D. Parks, 2021, Open Forum Infectious Diseases.

Cost-effectiveness and budget impact of dolutegravir/lamivudine for treatment of human immunodeficiency virus (HIV-1) infection in the United States

S. Anderson, A. Oglesby, L. Evitt, 2021, Journal of managed care & specialty pharmacy.